WORK Medical establishes US subsidiary for global expansion

WORK Medical Technology Group LTD (NASDAQ: WOK) announced the establishment of its U.S. subsidiary, Work Bio Technologies Ltd, incorporated in Nevada. The Chinese medical device supplier said the subsidiary will serve as its primary operational platform in the United States.

The wholly owned subsidiary, incorporated with Entity ID E56873592026-7 and EIN 42-2095406, is intended to strengthen WORK Medical's commercial presence and enhance supply chain management capabilities in the U.S. market. Wu Shuang, Chief Executive Officer and Chairman of WORK Medical, serves as President, Secretary, Treasurer, and Director of the new subsidiary.

The subsidiary is expected to support broader international expansion efforts by establishing an operational framework that integrates product distribution, supply chain management, and customer engagement across global markets, according to the company's statement.

WORK Medical develops and manufactures Class I and II medical devices through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. The company maintains a product portfolio of 23 items, including customized masks and medical consumables. Products are sold across 34 provincial-level administrative regions in China, with 15 products distributed to more than 30 countries worldwide.

The company has registered 17 products with the U.S. Food and Drug Administration for market entry. WORK Medical operates through subsidiaries in China and supplies disposable medical devices through various operating subsidiaries.

Wu Shuang stated that the establishment represents a milestone in the company's vision of becoming a globally connected life sciences and medical technology company, reflecting confidence in long-term strategy and commitment to serving international customers and partners.

You May Also Be Interested In

• After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO
• Court awards Biohaven and Yale $4M in trade secret case
• Advasa Holdings lists on Nasdaq under ticker ADBT